Skip to main content
. Author manuscript; available in PMC: 2014 May 1.
Published in final edited form as: Cancer J. 2013 May-Jun;19(3):247–262. doi: 10.1097/PPO.0b013e318292e51a

Table 2.

Effects of radiation therapy and chemotherapy on anti-tumor immunity

Component of immune response Potential effects of RT Potential effects of chemotherapy
Antigen presentation Translocation of calreticulin to cell surface activates dendritic and other antigen presenting cells7,106
Enhanced MHC class I expression30
Release of danger-associated molecular patterns (DAMPs) recruits and stimulates dendritic cells. 29
Increased antigen cross-presentation and dendritic cell activation107
Induction of immunogenic cell death44
T-cell response, trafficking Results in systemic inflammatory repsonse39
Release of alarmin and binding to TLR4 activates antitumor immunity108
CXCL16 release attracts effector T cells109
Tumor vascular endothelial changes promote immune cell extravasation8,110
Release of alarmin and binding to TLR4 activates antitumor immunity108
Increased intratumoral T cell accumulation111,112
Target destruction Tumor debulking Tumor debulking
Generation of memory Unknown Increasing memory against tumor antigen47

MHC, major histocompatibility complex; TLR, toll-like receptor